RICHMOND, Calif., Sept. 30, 2011 /PRNewswire/ — Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced that the company will hold a teleconference and webcast at 8:30 am ET, on Monday, October 3, 2011, to discuss results of the Phase 2b clinical trial (SB-509-901) from its ZFP…
Popularity: 2% [?]

